Brief: Achieve Life Sciences Q3 EPS USD -0.34
Nov 9 (Reuters) - Achieve Life Sciences Q3 EPS USD -0.34. * Q3 operating expenses USD 6.572 million * Q3 net income USD -7.108 million * Q3 income from operations USD -6.572 million
Recent news on Achieve Life Sciences
See all newsAchieve Life Sciences Q3 net loss and loss per share beat estimates
Brief: Achieve Life Sciences Presents 52-Week Cytisinicline Results For Smoking And Vaping Cessation At Chest 2026
Brief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Achieve Life Sciences Appoints Kaitlyn Tuson As Senior Vice President, Marketing And Communications
Brief: Achieve Life Sciences - Enters ATM Sale Agreement With Jefferies For Up To $150 Million In Common Stock